Related Experiment Videos
A comparison between two screening methods for detection of microproteinuria
K Higby1, C R Suiter, T Siler-Khodr
1Department of Obstetrics and Gynecology, Brooke Army Medical Center, Fort Sam Houston, TX 78234-6200, USA.
Objective:
We compared two screening tests for microproteinuria with 24-hour quantitative measurements to determine which method is better at predicting clinically significant proteinuria.
Study Design:
We obtained 690 24-hour urine collections from both low- and high-risk patients seen for prenatal care. Qualitative screening for microproteinuria on the basis of the protein-error-of-indicators principle (Ames Multistix 10SG and Micro-bumintest, Miles Diagnostic Division, Elkhart, Ind.) was done by the same investigator (C.S.). Quantitative assay was done by use of pyrogallol red-molybdate for total protein and by radioimmunoassay for albumin.
Results:
The Micro-bumintest had a sensitivity of 87% compared with 36% for the Multistix 10SG. It also had a higher specificity and higher positive and negative predictive values. The Micro-bumintest was a better screening test in patients with significant protein excretion (> 300 mg/24 hours).
Conclusion:
The Micro-bumintest has a much higher sensitivity and a lower false-negative rate than does the Multistix 10SG. Our data support the Micro-bumintest as a better screening test for clinically significant proteinuria.
Insights
The Micro-bumintest is a superior screening test for detecting clinically significant proteinuria, demonstrating higher sensitivity and a lower false-negative rate compared to the Ames Multistix 10SG.
Area of Science:
- Nephrology
- Clinical Chemistry
- Prenatal Care
Background:
- Microproteinuria is a key indicator of kidney damage, particularly during pregnancy.
- Accurate screening for microproteinuria is crucial for timely intervention and management of preeclampsia.
- Existing screening methods vary in their diagnostic accuracy.
Purpose of the Study:
- To compare the diagnostic performance of two qualitative screening tests for microproteinuria: Ames Multistix 10SG and Micro-bumintest.
- To determine which test better predicts clinically significant proteinuria (> 300 mg/24 hours) in prenatal care patients.
- To evaluate sensitivity, specificity, and predictive values of each screening method.
Main Methods:
- A prospective study involving 690 24-hour urine collections from low- and high-risk prenatal patients.
- Qualitative screening using Ames Multistix 10SG and Micro-bumintest based on the protein-error-of-indicators principle.
- Quantitative protein and albumin assays performed using pyrogallol red-molybdate and radioimmunoassay, respectively.
Main Results:
- Micro-bumintest exhibited a sensitivity of 87% versus 36% for Multistix 10SG.
- Micro-bumintest demonstrated higher specificity and superior positive and negative predictive values.
- The Micro-bumintest proved more effective in identifying patients with significant protein excretion.
Conclusions:
- Micro-bumintest offers significantly higher sensitivity and a reduced false-negative rate compared to Multistix 10SG.
- The Micro-bumintest is recommended as a more reliable screening test for clinically significant proteinuria in prenatal settings.